Freedom Investment Management, Inc. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2019$667,000
-34.2%
5,801
-1.2%
0.06%
-31.8%
Q2 2019$1,013,000
-1.7%
5,874
-3.9%
0.08%
+2.4%
Q1 2019$1,030,000
+120.6%
6,110
+27.5%
0.08%
+130.6%
Q4 2018$467,000
-32.9%
4,794
-1.4%
0.04%
-18.2%
Q3 2018$696,000
+2.7%
4,861
+0.0%
0.04%
+7.3%
Q2 2018$678,000
+46.4%
4,859
+18.3%
0.04%
+70.8%
Q1 2018$463,000
-7.4%
4,109
+8.4%
0.02%
-7.7%
Q4 2017$500,000
+46.2%
3,791
+12.6%
0.03%
+36.8%
Q3 2017$342,000
+17.5%
3,367
+16.1%
0.02%
+11.8%
Q2 2017$291,000
+2.5%
2,899
+23.3%
0.02%0.0%
Q1 2017$284,0002,3520.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders